Roche Diagnostics Corp.’s North American business, which is headquartered in Indianapolis, posted a 4-percent boost in sales last year on the strength of its fluid analyzer business unit, even though its diabetes sales fell.
A Johnson County man whose home is listed for sheriff’s sale and who has filed for bankruptcy protection twice and been convicted of check fraud managed to convince several Indianapolis cultural institutions that he was good for multimillion-dollar gifts.
John Ryan, 39, started with Hall Render Killian Heath & Lyman P.C. straight out of Indiana University law school and took only 12 years to ascend to president and managing partner of the Indianapolis-based law firm.
The achievements of Bryan Schneider, 38, in breast cancer research continue to build on each other.
Sometimes your “dream job” isn’t all it’s cracked up to be. That’s what Derek Empie, 39, former broadcast sports professional-turned-attorney, discovered after several years working for NBC Sports, ESPN and Turner Broadcasting.
John Kunzer, 35, credits his success to a long list of mentors, starting with his grandfather, a chemistry professor who took him to his office on Sundays and stressed the importance of education.
Ryan Kitchell, 38, didn’t expect to be overseeing health plans for Indiana University Health and its 80,000 members. But he’s found himself in unexpected places before, with good results.
As executive director of the Alliance for Health Promotion, Kim Irwin, 38, is a master of bringing organizations together for the common good.
Charlie Miramonti, 36, used to be “the long-haired hippie kid who didn’t care about anything.” Then he found something that moved him, someplace he could make a difference: emergency medical services.
Kokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than four months after it broke off a merger deal with Indiana University Health.
After 15 years of increasing yelps from primary care doctors, WellPoint Inc. is finally launching a plan to pay more for the family doctor’s time. The Indianapolis-based health insurer said Jan. 27 that it will increase the fees it pays to primary care specialists and even start paying for such services as crafting care plans for patients with complex medical problems. It also will offer doctors an opportunity to share in some savings when better patient care leads to a reduction in costs. An example of what WellPoint has is mind is paying doctors to take the time to coach overweight patients who have diabetes to develop an exercise plan and then making sure they stay on it. "It makes the physician the kind of physician their patient wants them to be," Jill Hummel, WellPoint's vice president of payment innovation, told the Associated Press. WellPoint reasons that by spending more at the primary care level, it can cut down on emergency room visits and hospital admissions—which are the most expensive types of care. Primary care doctors say low reimbursement rates force them to cram as many patient visits as possible into a typical day in order to make enough money to stay afloat. That keeps them from spending more than a few minutes with each patient. For a time, physicians made extra money by starting their own imaging and diagnostic centers. But health plans—both governmental and private—sharply curtailed payments to physician-owned facilities, sharply curtailing that source of revenue.
The third time’s a charm. California-based Amylin Pharmaceuticals Inc. and Massachuetts-based Alkermes Inc. succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s Byetta diabetes shot. The companies had been developing Bydureon with Eli Lilly and Co. until November. But Indianapolis-based Lilly broke off its partnership with Amylin after the two companies feuded over Lilly’s agreement to sell a competing diabetes medicine with Germany-baseed Boehringer Ingelheim GmbH. Amylin also agreed to make a one-time payment of $250 million to Lilly and to pay as much as $1.2 billion in royalties based on future sales of Bydureon and Byetta. In the meantime, Lilly is working to develop its own version of Bydureon, which is called dulaglutide. In 2010, Byetta produced revenue of about $700 million for the two companies, but its market share had been dented significantly by a once-daily version of the medicine, called Victoza, which was launched in 2010 by Denmark-based Novo Nordisk A/S.
Actress Florence Henderson—better known as Carol Brady from “The Brady Bunch”—will star in a series of advertisements for American Senior Communities LLC, an Indianapolis-based chain of nursing homes and long-term care facilities. The campaign will debut statewide this week in television, radio and print. Henderson, a native of Dale, currently hosts “The Florence Henderson Show” on Retirement Living Television and recently released her autobiography, “Life is Not a Stage.” Henderson previously served as a spokeswoman for Oldsmobile, Polident, Tang, Rain Soft, Pepsi and Wesson Oil. The advertising campaign was created and produced by Indianapolis-based marketing firm Bohlsen Group.
Joseph Bilby’s Trafalgar home is listed for sheriff’s sale. He’s filed for bankruptcy protection twice since 1991, and in 2010 he pleaded guilty to three counts of check fraud. Yet leaders of several Indianapolis cultural institutions believed, at least at first, that he was good for multi-million-dollar gifts. The Eiteljorg Museum of Native American and […]
Health insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn’t currently cover, changes that could give patients more quality time with their doctors.
There is statistical evidence that licensing acts as a barrier to entry into a profession, and also as a barrier to labor mobility (since states have different requirements, licenses are considerably less portable than one might imagine).
As an attorney who has practiced labor and employment law for 37 years, I’m concerned by the widespread confusion about the so-called “right-to-work“ bill being promoted by Gov. Daniels.
U.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
A number of acquisitions last year disclosed no sale price. In the Indianapolis area, those deals ranged from MacAllister Machinery’s purchase of a Caterpillar dealership in Michigan to Herff Jones’ acquisition of a Memphis, Tenn.-headquartered maker of cheerleading uniforms.
We are all selfish for wanting him to stay on the field and entertain us.
Why not recognize real local contribution rather than celebrity?
